10-Oxo Docetaxel is primarily utilized in the field of cancer research and therapy. It serves as a derivative of Docetaxel, a well-known chemotherapeutic agent, and is studied for its potential to enhance the efficacy and reduce the side effects of cancer treatments. Researchers explore its application in targeting various types of cancers, particularly those resistant to conventional therapies. Its role in inhibiting cell division by stabilizing microtubules makes it a valuable compound in developing advanced oncological treatments. Additionally, it is investigated for its potential in combination therapies, aiming to improve patient outcomes and reduce relapse rates.